Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$958M |
| 2 |
AbbVie
ABBV
|
+$955M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$762M |
| 4 |
CRH
CRH
|
+$705M |
| 5 |
Walmart Inc
WMT
|
+$700M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$604M |
| 2 |
DuPont de Nemours
DD
|
+$568M |
| 3 |
Applied Materials
AMAT
|
+$558M |
| 4 |
IPG
Interpublic Group of Companies
IPG
|
+$277M |
| 5 |
Blackstone
BX
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.03% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Communication Services | 10.05% |
| 5 | Healthcare | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Arq
ARQ
$99.6M
| $2.54M | ﹤0.01% |
778,142
+3,505
| +0.5% | +$17.1K |
|
3077
LENSAR
LNSR
$102M
| $2.53M | ﹤0.01% |
217,730
-156
| -0.1% | -$1.78K |
|
3078
Hamilton Beach Brands
HBB
$447M
| $2.51M | ﹤0.01% |
152,615
+469
| +0.3% | +$7.11K |
|
3079
Digimarc Corp
DMRC
$158M
| $2.51M | ﹤0.01% |
382,110
-9,343
| -2% | -$79.2K |
|
3080
Kyverna Therapeutics
KYTX
$500M
| $2.51M | ﹤0.01% |
266,402
-11,927
| -4% | -$88.5K |
|
3081
Alto Ingredients
ALTO
$326M
| $2.5M | ﹤0.01% |
868,804
-51,107
| -6% | -$96.4K |
|
|
MSB
3082
Mesabi Trust
MSB
$305M
| $2.5M | ﹤0.01% |
64,866
+5,189
| +9% | +$176K |
|
3083
Galectin Therapeutics
GALT
$356M
| $2.49M | ﹤0.01% |
598,074
-34,993
| -6% | -$184K |
|
3084
VTEX
VTEX
$630M
| $2.49M | ﹤0.01% |
661,933
-33,479
| -5% | -$137K |
|
3085
CF Bankshares
CFBK
$235M
| $2.48M | ﹤0.01% |
99,447
+12,416
| +14% | +$296K |
|
3086
BRC Inc
BRCC
$212M
| $2.48M | ﹤0.01% |
2,234,710
+151,438
| +7% | +$196K |
|
3087
Ericsson
ERIC
$33.6B
| $2.48M | ﹤0.01% |
257,021
+6,667
| +3% | +$63.1K |
|
3088
Geospace Technologies
GEOS
$66.5M
| $2.47M | ﹤0.01% |
146,107
+3,507
| +2% | +$70.4K |
|
|
NREF
3089
NexPoint Real Estate Finance
NREF
$318M
| $2.45M | ﹤0.01% |
174,155
-11,799
| -6% | -$165K |
|
3090
TransAlta
TAC
$3.99B
| $2.45M | ﹤0.01% |
189,615
+25,282
| +15% | +$377K |
|
|
CTNM
3091
Contineum Therapeutics
CTNM
$576M
| $2.45M | ﹤0.01% |
213,869
+2,819
| +1% | +$32.2K |
|
3092
American Vanguard Corp
AVD
$62.8M
| $2.44M | ﹤0.01% |
638,964
-14,053
| -2% | -$65.7K |
|
3093
Advantage Solutions
ADV
$423M
| $2.43M | ﹤0.01% |
110,545
+860
| +0.8% | +$24.9K |
|
3094
Vor Biopharma
VOR
$1.38B
| $2.43M | ﹤0.01% |
185,808
+158,416
| +578% | +$2.95M |
|
3095
Fate Therapeutics
FATE
$294M
| $2.43M | ﹤0.01% |
2,468,348
-61,864
| -2% | -$74.3K |
|
3096
Forrester Research
FORR
$224M
| $2.42M | ﹤0.01% |
298,429
+5,793
| +2% | +$45.5K |
|
3097
Journey Medical
DERM
$183M
| $2.42M | ﹤0.01% |
313,970
+36,124
| +13% | +$283K |
|
3098
iShares MSCI Kuwait ETF
KWT
$69.4M
| – | – |
0
| – | – |
|
3099
Pharvaris
PHVS
$2.38B
| $2.41M | ﹤0.01% |
86,801
+8,261
| +11% | +$199K |
|
3100
KRONOS Worldwide
KRO
$996M
| $2.39M | ﹤0.01% |
541,095
+8,641
| +2% | +$42K |
|
Similar funds
Geode Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Geode Capital Management held 4,586 positions worth $1.62T, up 3.4% from $1.57T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q4 2025 filing shows 113 new, 2,855 increased, 1,222 reduced and 117 closed positions. Its largest new stake was Qnity Electronics Inc: 5,358,208 shares worth $436M. The largest sale was Kellanova, an estimated $604M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q4 2025 buy was Qnity Electronics Inc: 5,358,208 shares worth $436M.
- Geode Capital Management added most to Microsoft in Q4 2025, an estimated $958M increase.
- Geode Capital Management's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $568M.
- Geode Capital Management fully exited Kellanova in Q4 2025, selling an estimated $604M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.62T portfolio in Q4 2025.
- Geode Capital Management opened 113 new positions and closed 117 in Q4 2025.
- Geode Capital Management's portfolio value rose 3.4% quarter-over-quarter to $1.62T.
Based on Geode Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.